Salt Screening Studies – A Simple Path to the Clinic

For orally dosed compounds, the dissolution rate enhancement that can be achieved using a salt strategy can markedly improve bioavailability and remove the need for enabling formulation approaches, simplifying the path to the clinic. Selection of appropriate counterions can also be used to fine-tune dissolution rates, an approach that has been used to successfully improve lung retention for dry powder inhaled dosing.

Take this quiz to quickly learn more about whether your compound’s best route to formulation. Charles River offers services such as inhaled formulation – lactose stability/blending, excipient compatibility studies – with a range of excipients, capsule dissolution studies (non-ICH).

Formulation Studies – Where Should I Begin?
Answer a few quick questions to learn next steps, how much material you will need, and process workflow and timing as well as considerations to achieve success.
Begin here

When the free form of a drug is difficult to crystallise or has challenging handling properties, a salt screening drug development strategy gives an opportunity to identify a solid form that is easier to work with, simplifying material supply planning and reducing the risk of delays to your pre-clinical program. 

Salt Screening Studies and Intellectual Property (IP)

Novel salt forms are also patentable and can therefore can add value to your program by strengthening your IP position.

Combining a salt screening drug development strategy with thorough polymorphism screening puts you in the best possible position to identify the optimum solid form of your drug. Our experts have extensive experience in these areas and are ideally placed to guide you through the process.

Question for our Chemists?

 

Frequently Asked Questions (FAQs) About Salt Screening